Gluten, Pain, and Mental Health: A Spanish Study

A study of 526 Spanish adults without celiac disease found a mean daily gluten intake of 11.14 grams, with significant variation across the population. This research, published in *Frontiers in Nutrition*, provides the first direct estimate of gluten consumption in Spain and links higher intake to small but measurable increases in self-reported stress, anxiety, depression, and skin symptoms.

How Researchers Measured Gluten Intake

To establish a baseline for gluten exposure, authors David Granizo Bermejo, Antonio Molina-López, and Diego Domínguez-Balmaseda conducted a cross-sectional online survey. They recruited adults who did not have celiac disease or a known gluten intolerance. Gluten consumption was not measured directly from food but estimated using a detailed food frequency questionnaire. The team then applied the Osborne method, a technique that calculates gluten content based on the known protein composition of wheat, barley, and rye products. The study also collected data on participants’ mental health, chronic pain, sleep quality, and skin symptoms through validated questionnaires.

Gluten Consumption Patterns and Symptom Links

The analysis revealed a mean intake of 11.14 grams of gluten per day, with a wide range from 0 to over 82 grams. Consumption was higher in men and in younger age groups. The central finding was a series of weak but clear statistical links between higher gluten intake and reports of poorer mental well-being. Correlations were positive for stress (r = 0.140), anxiety (r = 0.100), depression (r = 0.172), and insomnia (r = 0.141).

Participants who reported skin problems, which comprised 34.98% of the sample, consumed significantly more gluten. The study found no significant difference in gluten intake between those with and without chronic pain. The researchers note that while the associations are statistically significant, the effect sizes are small, meaning gluten intake explains only a tiny portion of the variation in these symptoms. This reinforces the complex, multi-factorial nature of conditions like IBS and mood disorders.

The Critical Confounder: Gluten vs. Fructans

A major limitation highlighted by the authors is the inability to separate the effects of gluten from those of fructans. Fructans are a type of fermentable oligosaccharide (FODMAP) found in the same wheat-based foods that contain gluten. They are a well-established trigger for functional gut symptoms in sensitive individuals, particularly those with IBS or SIBO.

“Gluten co-occurs with fructans in the same wheat-based foods, so the weak associations observed cannot be attributed specifically to gluten,” the authors state. This is a vital consideration for patients and clinicians. Someone who feels better on a gluten-free diet may actually be responding to the concurrent reduction in fructans and other fermentable carbohydrates, not the gluten protein itself.

Practical Implications for Gut and Mental Health

This study does not prove that gluten causes anxiety or depression in the general population. The correlations are modest and observational, leaving open the possibility that other dietary or lifestyle factors are responsible. However, it adds to a body of evidence suggesting that diet quality can influence the gut-brain axis.

For individuals experiencing unexplained gut, skin, or mood symptoms, the findings suggest a practical step: consider a detailed dietary assessment. Tracking intake of wheat-based products could reveal patterns. Under professional guidance, a short-term elimination diet, such as a low-FODMAP protocol that reduces both fructans and gluten, followed by structured reintroduction, can help identify specific triggers. This is more informative than broadly avoiding gluten without testing which component is problematic.

The research also provides a necessary reference point. With an estimated average intake of over 11 grams per day, future studies on non-celiac gluten sensitivity or challenge protocols have a clearer picture of typical exposure levels in a Mediterranean diet context.

Study Limitations and Future Research Directions

The authors are explicit about the constraints of their work. The sample was not representative of Spain—85% were women, and 57.4% were aged 35–49. Gluten intake was not adjusted for total energy intake, so people who eat more food in general would naturally consume more gluten. The use of self-reported data for both diet and symptoms can introduce bias.

Future research requires more precise methods. Studies that measure specific immune or gut barrier responses to isolated gluten, compared to isolated fructans, in controlled settings are needed. Investigating how these dietary components interact with the gut microbiome to produce systemic effects will be key. As the authors conclude, their findings “suggest a possible role of dietary gluten in extra intestinal symptomatology” but must be interpreted with caution until more definitive evidence is available.

Source: Bermejo DG, Molina-López A, Domínguez-Balmaseda D. Daily gluten intake and its association with extra intestinal symptoms in non-celiac adults: a cross-sectional study. Front Nutr. 2026;13:1909893. doi:10.3389/fnut.2026.1909893.